Arecor Therapeutics plc announced that it has entered into an agreement with a leading biopharmaceutical company to support the ongoing development of a biosimilar product. This revenue-generating collaboration follows an earlier technology partnership between the two companies, utilising Arecor's proprietary technology platform, Arestatâ„¢, and formulation expertise.